Trials / Recruiting
RecruitingNCT06028165
CABG Based on CT-FFR Versus Conventional Coronary Angiography
A Prospective, Randomized Comparison of Coronary Artery Bypass Grafting Based on COmputed Tomography-derived Fractional Flow REserve Versus Angiography (CABG-COREA Trial)
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 96 (estimated)
- Sponsor
- Myongji Hospital · Academic / Other
- Sex
- All
- Age
- 40 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The aims of study are (1) to compare early and 1-year graft patency rates in patients who underwent coronary artery bypass grafting (CABG) based on conventional coronary angiography(CAG) versus cardiac computed tomography(CT)-derived fractional flow reserve(FFR), and (2) to demonstrate difference in clinical outcomes between the 2 groups.
Detailed description
The CABG-COREA trial is designed as a randomized, controlled trial to recruit 96 patients who undergo coronary artery bypass grafting. Patients were randomized by use of a randomization table. Coronary arteries are revascularized based on conventional coronary angiography (quantitative coronary angiography) or cardiac computed tomography-derived fractional flow reserve according to the randomization result. The primary end point is to evaluate early and 1-year postoperative graft patency. The secondary end points are overall survival, freedom from cardiac death and freedom from MACCE(major adverse cardiac or cerebrovascular events).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Coronary artery bypass grafting based on conventional coronary angiography | Revascularized coronary arteries are decided based on conventional coronary angiography (quantitative coronary angiography) |
| PROCEDURE | Coronary artery bypass grafting based on cardiac computed tomography-derived fractional flow reserve. | Revascularized coronary arteries are decided based on cardiac computed tomography-derived fractional flow reserve. |
Timeline
- Start date
- 2023-10-20
- Primary completion
- 2024-10-01
- Completion
- 2025-10-01
- First posted
- 2023-09-08
- Last updated
- 2024-07-05
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT06028165. Inclusion in this directory is not an endorsement.